| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection A Oliver, R Cantón, P Campo, F Baquero, J Blázquez Science 288 (5469), 1251-1253, 2000 | 1558 | 2000 |
| Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study M Pollán, B Pérez-Gómez, R Pastor-Barriuso, J Oteo, MA Hernán, ... The Lancet 396 (10250), 535-544, 2020 | 537 | 2020 |
| Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli J Rodríguez-Baño, JC Alcalá, JM Cisneros, F Grill, A Oliver, JP Horcajada, ... Archives of internal medicine 168 (17), 1897-1902, 2008 | 514 | 2008 |
| ESCMID guideline for the diagnosis and treatment of biofilm infections 2014 N Høiby, T Bjarnsholt, C Moser, GL Bassi, T Coenye, G Donelli, ... Clinical microbiology and infection 21, S1-S25, 2015 | 439 | 2015 |
| OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumanniiclinical strain G Bou, A Oliver, J Martínez-Beltrán Antimicrobial Agents and Chemotherapy 44 (6), 1556-1561, 2000 | 426 | 2000 |
| Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis J Rodríguez-Baño, E Picón, P Gijón, JR Hernández, M Ruíz, C Peña, ... Clinical infectious diseases 50 (1), 40-48, 2010 | 388 | 2010 |
| The increasing threat of Pseudomonas aeruginosa high-risk clones A Oliver, X Mulet, C López-Causapé, C Juan Drug Resistance Updates 21, 41-59, 2015 | 352 | 2015 |
| Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections MD Maciá, D Blanquer, B Togores, J Sauleda, JL Pérez, A Oliver Antimicrobial agents and chemotherapy 49 (8), 3382-3386, 2005 | 338 | 2005 |
| Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000) TM Coque, A Oliver, JC Pérez-Díaz, F Baquero, R Cantón Antimicrobial agents and chemotherapy 46 (2), 500-510, 2002 | 296 | 2002 |
| Characterization of clinical isolates ofKlebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β-lactamase … CD Steward, JK Rasheed, SK Hubert, JW Biddle, PM Raney, ... Journal of clinical microbiology 39 (8), 2864-2872, 2001 | 294 | 2001 |
| Outbreak of a Multiresistant Klebsiella pneumoniae Strain in an Intensive Care Unit: Antibiotic Use as Risk Factor for Colonization and Infection A Asensio, A Oliver, P González-Diego, F Baquero, JC Perez-Diaz, P Ros, ... Clinical Infectious Diseases 30 (1), 55-60, 2000 | 276 | 2000 |
| Coevolution with viruses drives the evolution of bacterial mutation rates C Pal, MD Maciá, A Oliver, I Schachar, A Buckling Nature 450 (7172), 1079-1081, 2007 | 273 | 2007 |
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants A Oliver, F Baquero, J Blázquez Molecular microbiology 43 (6), 1641-1650, 2002 | 266 | 2002 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 255 | 2017 |
| Antimicrobial susceptibility testing in biofilm-growing bacteria MD Macia, E Rojo-Molinero, A Oliver Clinical Microbiology and Infection 20 (10), 981-990, 2014 | 254 | 2014 |
| Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation A Mena, EE Smith, JL Burns, DP Speert, SM Moskowitz, JL Perez, ... Journal of bacteriology 190 (24), 7910-7917, 2008 | 240 | 2008 |
| β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver PLoS Pathog 5 (3), e1000353, 2009 | 232 | 2009 |
| Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals O Gutiérrez, C Juan, E Cercenado, F Navarro, E Bouza, P Coll, JL Pérez, ... Antimicrobial agents and chemotherapy 51 (12), 4329-4335, 2007 | 224 | 2007 |
| Chronic Pseudomonas aeruginosa Infection in Chronic Obstructive Pulmonary Disease L Martínez-Solano, MD Macia, A Fajardo, A Oliver, JL Martinez Clinical infectious diseases 47 (12), 1526-1533, 2008 | 212 | 2008 |
| Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH J Rodríguez-Baño, JR Paño-Pardo, L Alvarez-Rocha, Á Asensio, E Calbo, ... Enfermedades Infecciosas y Microbiología Clínica 30 (1), 22. e1-22. e23, 2012 | 202 | 2012 |
Carlos Juan Immunology associate professor (UIB), Microbiology Researcher Hospital Son Espases, PalmaVerified email at uib.cat
